X
Xin-Yi Tian
Researcher at Zhengzhou University
Publications - 11
Citations - 97
Xin-Yi Tian is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 1, co-authored 3 publications receiving 2 citations.
Papers
More filters
Journal ArticleDOI
Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.
Xiao-Jing Pang,Xiu-Juan Liu,Yuan Liu,Wen-Bo Liu,Yin-Ru Li,Guang-Xi Yu,Xin-Yi Tian,Yan-Bing Zhang,Jian Song,Cheng-Yun Jin,Sai-Yang Zhang +10 more
TL;DR: In this article, the structure and biological function of FAK are reviewed, and the design, chemical types, and activity of the FAK drugs are summarized according to the development of drugs, which provided the reference for the discovery of new anticancer agents.
Journal ArticleDOI
Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities.
Jian-Ying Song,Yong-Feng Guan,Wen-bo Liu,Chun Song,Xin-Yi Tian,Ting Zhu,X. Fu,Ying-Qiu Qi,Sai-Yang Zhang +8 more
TL;DR: Wang et al. as discussed by the authors designed, synthesized and evaluated as tubulin polymerization inhibitors targeting the colchicine binding site, and showed that compound MY-413 was a promising lead compound for the further investigation as a potential anti-gastric cancer agent.
Journal ArticleDOI
Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway.
Jian-Ying Song,Sheng-Hui Wang,Chun Song,Weixing Zhang,Jun Zhu,Xin-Yi Tian,X. Fu,Yan Xu,Cheng-Yun Jin,Sai-Yang Zhang +9 more
TL;DR: In this article , N-benzylarylamide saderivatives were designed and synthesized, and their antiproliferative activities were explored, and 51 target compounds exhibited potent inhibitory activities against MGC-803, HCT-116 and KYSE450 cells with IC50 values in two-digit nanomolar.
Journal ArticleDOI
Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers
Jian Song,Yuan Liu,Xin-Ying Yuan,Wen-Bo Liu,Yin-Ru Li,Guang-Xi Yu,Xin-Yi Tian,Yan-Bing Zhang,Xiang-Jing Fu,Sai-Yang Zhang,Sai-Yang Zhang +10 more
TL;DR: NEDDylation promotion induced by compound K3 is reported, which could inhibit the cancer cell lines MGC-803 and HGC-27 and induce thecancer cell apoptosis via prompting the degradation of c-IAP and YAP/TAZ.
Journal ArticleDOI
A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo.
Yin-Ru Li,Fang-Fang Liu,Wen-bo Liu,Yi-Fan Zhang,Xin-Yi Tian,X. Fu,Yan Xu,Jian-Ying Song,Sai-Yang Zhang +8 more
TL;DR: Wang et al. as discussed by the authors reported a novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo.